""

Downloads

AUSVAXSAFETY summary report 2020: 12-13 year infographic

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date: 
15 October 2021
Publication type: 
Infographic
Intended audience: 
General public
Description: 

12–13-year-olds receive vaccines for diphtheria, tetanus and whooping cough (included in the dTpa vaccine) and HPV.

For children who received HPV (1st dose) and dTpa vaccines together:

11,487 parents/carers responded to an SMS about their child’s health a few days after their vaccinations. 91% reported no adverse events. 9% reported any adverse event, including 0.6% who reported taking their child to a doctor or emergency department in the days after vaccination. The adverse events they reported were similar to the types of adverse events reported overall. 1,021 parents/carers reported one or more adverse events. The most commonly reported were injection site pain (349 reports), injection site swelling or redness (261 reports), tiredness (229 reports), headache (181 reports) and fever (130 reports). These symptoms are known to occur after vaccination. They are generally mild and short-lived. Aboriginal and Torres Strait Islander children who received these vaccines had the same rates and types of adverse events as other children.

For HPV vaccine (2nd dose) alone:

28,572 parents/carers responded to an SMS about their child’s health a few days after their vaccinations. 92% reported no adverse events. 8% reported any adverse event, including 0.3% who reported taking their child to a doctor or emergency department in the days after vaccination. The adverse events they reported were similar to the types of adverse events reported overall. 2,270 parents/carers reported one or more adverse events. The most commonly reported were injection site pain (1,258 reports), injection site swelling or redness (845 reports), headache (588 reports), tiredness (585 reports) and fever (256 reports). These symptoms are known to occur after vaccination. They are generally mild and short-lived. Aboriginal and Torres Strait Islander children who received these vaccines had the same rates and types of adverse events as other children.

Vaccines given at 12–13 years in 2020 are Gardasil 9 (protects against HPV [human papillomavirus]) and Boostrix (protects against diphtheria, tetanus, whooping cough [dTpa]).

Part of a collection: